Neuroprotection in the newborn infant
- PMID: 19944839
- PMCID: PMC2786822
- DOI: 10.1016/j.clp.2009.07.013
Neuroprotection in the newborn infant
Abstract
Neonatal brain injury is an important cause of death and disability, with pathways of oxidant stress, inflammation, and excitotoxicity that lead to damage that progresses over a long period of time. Therapies have classically targeted individual pathways during early phases of injury, but more recent therapies such as growth factors may also enhance cell proliferation, differentiation, and migration over time. More recent evidence suggests combined therapy may optimize repair, decreasing cell injury while increasing newly born cells.
References
-
- Wu YW, Backstrand KH, Zhao S, Fullerton HJ, Johnston SC. Declining diagnosis of birth asphyxia in California: 1991-2000. Pediatrics. 2004 Dec;114(6):1584–1590. - PubMed
-
- Nelson KB, Lynch JK. Stroke in newborn infants. Lancet Neurol. 2004 Mar;3(3):150–158. - PubMed
-
- Gressens P, Luton D. Fetal MRI: obstetrical and neurological perspectives. Pediatr Radiol. 2004 Sep;34(9):682–684. - PubMed
-
- Miller SP, McQuillen PS, Hamrick S, et al. Abnormal brain development in newborns with congenital heart disease. N Engl J Med. 2007 Nov 8;357(19):1928–1938. - PubMed
-
- Dilenge ME, Majnemer A, Shevell MI. Long-term developmental outcome of asphyxiated term neonates. J Child Neurol. 2001 Nov;16(11):781–792. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
